2Q14 Results: Cemargos - Underperform
Inorganic growth boosted financials; local operations showed some weakness in 2Q14
Price: COP 11,600; Target Price: COP 9,950
Ideas get bigger when you share them...
July 24, 2014 (www.investorideas.com newswire) The company released its financial results for 2Q14 reporting double-digit growth along its operating and bottom-line figures. However, we highlight that growth was mainly driven by inorganic growth coming from the operations acquired in USA, Honduras, and French Guiana. On the other hand, the operations in Colombia posted a weak quarter with revenues and EBITDA falling 3.4% and 15.7% y/y, respectively. Given the negative performance from the operations in Colombia we highlight that financial results were below our expectations, especially on EBITDA and the net earnings.
During 2Q14 consolidated cement volumes grew 13.8% y/y (3.26 mn MT), while concrete volumes increased 21.6% (2.92 mn m3). Growth in volumes include a full quarter of Honduras and Florida, while Argos also consolidated 81 days from the operations of French Guiana. Despite this positive result driven by inorganic growth, we highlight that operations in Colombia showed weakness.
The negative performance from this regional was mainly related to weak volumes and prices. In addition, there were also non-recurring expenses related to the distribution center in Cartagena and the closing of a grinding facility in Barranquilla that have resulted in COP 43,000 mn. Nevertheless, we highlight that Cemargos expects to increase efficiency through these actions. On the other hand, we highlight that the positive effect from the new operation in Honduras was partially offset by lower volumes of concrete in Panama due to a strike in the Panama Canal operation.
On the positive side, the company continues to post a favorable turnaround in the USA operation. During 2Q14, Argos posted COP 47,000 mn in EBITDA relative to a negative figure of COP 13,000 mn reported in 2Q13.
La información contenida en este mensaje es confidencial y para conocimiento exclusivo del destinatario. La información y opiniones contenidas en este mensaje pertenecen únicamente al remitente, excepto cuando en el cuerpo del mensaje se establezca lo contrario y el remitente esté autorizado para enviar dicha información con carácter definitivo y oficial de Credicorp Capital. La información relacionada con su cuenta, los extractos, informes financieros y de productos, sólo será vinculante en la medida en que sea remitida por los canales y en los formatos que Credicorp Capital determine. Las opiniones, conclusiones o cualquier otra clase de información contenida en este correo no relacionadas con los fines del negocio de Credicorp Capital, deben entenderse como personales y bajo ninguna circunstancia son avaladas por Credicorp Capital. Si usted ha recibido este mensaje por error por favor proceda a eliminarlo, y notificar al remitente. De cualquier manera, usted no debe usar, divulgar, revelar, distribuir, imprimir, copiar o adulterar en forma parcial o total este mensaje. Credicorp Capital no se hace responsable por la eventual transmisión de virus o programas dañinos por este medio. Credicorp Capital, no se responsabiliza por eventuales daños o alteraciones como consecuencia de la recepción o uso del presente mensaje.
To View Complete Report: Cemargos 2Q14
This news is published on the Investorideas.com Newswire and its syndicated partner network
Get free news alerts:
Sign up here
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and global syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions and advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.